|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/68 |
| (11) | Number of the document | 3120148 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15710817.6 |
| Date of filing the European patent application | 2015-03-20 | |
| (97) | Date of publication of the European application | 2017-01-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/055981 |
| Date | 2015-03-20 |
| (87) | Number | WO 2015/140317 |
| Date | 2015-09-24 |
| (30) | Number | Date | Country code |
| 14305406 | 2014-03-21 | EP | |
| 14306528 | 2014-09-30 | EP |
| (72) |
HESS, Sybille, DE
GERSTEIN, Hertzel, CA
PARE, Guillaume, CA
MCQUEEN, Matthew, CA
|
| (73) |
Sanofi-Aventis Deutschland GmbH,
Brüningstra e 50, 65929 Frankfurt am Main,
DE
McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8, CA |
| (54) | NEW MARKERS FOR THE ASSESSMENT OF THE RISK FOR DEVELOPMENT OF A CARDIOVASCULAR DISORDER |
| NEW MARKERS FOR THE ASSESSMENT OF THE RISK FOR DEVELOPMENT OF A CARDIOVASCULAR DISORDER |